Serological Screening of Patients Diagnosed with Alveolar Echinococcus Disease in Their Home Regions
,
Abstract
Background: We aimed to determine the prevalence of Alveolar echinococcusis using ELISA in our region, to perform the specific differentiation of species by using the Western Blott method, to diagnose and treat this disease effectively in early periods, and to inform the patients about the results quickly.
Methods: From the provinces of Erzurum, Kars, Ardahan, Iğdır, Ağrı and Erzincan in the Eastern Anatolia Region, Turkey in August-September 2017, blood samples were provided from 305 participants (volunteer patients and their relatives), including 151 females (49.50%), whose ages ranged between 6-85 yr and were diagnosed as Alveolar echinococcosis (AE) and operated in concerned clinics.
Results: EIgG ELISA was determined as positive in 29 (9.5%) participants, including 17 (11.3%) females and 12 (7.8%) males. In addition, Em2-Em18 ELISA was also determined as positive in 15 (4.9%) participants, including 9 (6%) females and 6 (3.9%) males. Tweleve (3.94 %) of these findings were observed as positive in terms of both tests. Through the verification done by Anti-EWB IgG, Echinococcus multilocularis (EM) was identified in 7 (21.9%) of the female participants, E. granulosus (EG) in 1 (3.1%), and both parasites in 2 (6.2%). For male participants, EM was determined in 3 (9.3%) of them, EG in 1 (3.1%), and both parasites in 1 (3.1%).
Conclusion: AE continues to threaten public health in the region. In families where AE is detected positive, the reason for disease is based on nutrition; thus, it will be proper to check up all family members in the terms of infection.
2. Aydin Y, Ogul H, Topdagi O, et al. Relevance of pulmonary alveolar echinococcosis. Arch Bronconeumol (Engl Ed).2020;56(12):779-783.
3. Aydın Y, Altuntaş B, Eroğlu A, Oğul H, Aydınlı B. Treatment approach for pulmonary alveolar echinococcosis. Turk Gogus Kalp Dama. 2017;25(2):223-229.
4. Sakalar Ç, Kuk S, Erensoy A, et al. Molecular discrimination of Echinococcus granulosus and Echinococcus multilocularis by sequencing and a new PCR-RFLP method with the potential use for other Echinococcus species. Turk J Med Sci.. 2014; 44(5):741-748.
5. Sari C, Ertuğ S, Karadam SY, Ozgün H, Karaoğlu AO, Ertabaklar H. The comparative evaluation of Enzyme Linked Immunosorbent Assay (ELISA), Indirect Hemagglutination Test (IHA) and Indirect Fluorescent Antibody Test (IFAT) in the diagnosis of cystic echinococcosis. Turkiye Parazitol Derg. 2009;33(1):73-76.
6. Miman Ö, Yazar S. Alveolar echinococcosis in Turkey: in the light of the literature. Turkiye Parazitol Derg. 2002; 36(2):116.
7. Bart J-M, Piarroux M, Sako Y. et al. Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagn Microbiol Infect Dis. 2007; 59(1):93-95.
8. Ito A, Ma L, Paul M, Stefaniak J, Pawlowski ZS. Evaluation of Em18-, Em16-, antigen B-Western blots, Em2plus-ELISA and four other tests for differential serodiagnosis of alveolar and cystic echinococcosis patients in Poland. Parasitol Int. 1998; 47(2):95-99.
9. Ito A, Sako Y, Yamasaki H, et al. Development of Em18-immunoblot and Em18-ELISA for specific diagnosis of alveolar echinococcosis. Acta Trop. 2003; 85(2):173-182.
10. Ito A, Sako Y, Yamasaki H, et al. Differential serodiagnosis for cystic and alveolar echinococcosis using fractions of Echinococcus granulosus cyst fluid (antigen B) and E. multilocularis protoscolex (EM18). Am J Trop Med Hyg. 1999; 60(2):188-192.
11. Ito A, Schantz PM, Wilson JF. Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg. 1995; 52(1):41-44.
12. Ito A, Xiao N, Liance M, et al. Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test. J Clin Microbiol. 2002; 40(11):4161-4165.
13. Jiang L, Xu XN, Li X, Xue HC, Feng Z. Identification of the immunodominant regions of the Em18 antigen and improved serodiagnostic specificity for alveolar echinococcosis. Parasite Immunol. 2004;26(10):377-385.
14. Sako Y, Nakao M, Nakaya K, et al. Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol. 2002; 40(8):2760-2765.
15. Sako Y, Nakao M, Nakaya K, Yamasaki H, Ito A. Recombinant antigens for serodiagnosis of cysticercosis and echinococcosis. Parasitol Int. 2006; 55: 69-S73.
16. Xiao N, Mamuti W, Yamasaki H, et al. Evaluation of use of recombinant Em18 and affinity-purified Em18 for serological differentiation of alveolar echinococcosis from cystic echinococcosis and other parasitic infections. J Clin Microbiol. 2003; 41(7):3351-3353.
17. Gottstein B, Frey CF, Campbell-Palmer R, et al. Immunoblotting for the serodiagnosis of alveolar echinococcosis in alive and dead Eurasian beavers (Castor fiber). Vet Parasitol. 2014; 205(1-2):113-118.
18. Jeong J-S, Han SY, Kim YH, et al. Serological and molecular characteristics of the first Korean case of Echinococcus multilocularis. Korean J Parasitol. 20131; 51(5):595.
19. Tappe D, Grüner B, Kern P, Frosch M. Evaluation of a commercial Echinococcus Western Blot assay for serological follow-up of patients with alveolar echinococcosis.
Clin Vaccine Immunol. 2008;15(11):1633-1637.
| Files | ||
| Issue | Vol 17 No 4 (2022) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijpa.v17i4.11283 | |
| Keywords | ||
| Echinococcosis Echinococcus multilocularis Western blot Echinococcus alveolaris | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
